Ekso Bionics Holdings Inc (EKSO)
1.29
+0.02
(+1.18%)
USD |
NASDAQ |
May 02, 16:00
1.275
-0.02
(-1.16%)
After-Hours: 20:00
Ekso Bionics Holdings Free Cash Flow: -12.21M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -12.21M |
| September 30, 2023 | -14.28M |
| June 30, 2023 | -13.64M |
| March 31, 2023 | -14.93M |
| December 31, 2022 | -14.88M |
| September 30, 2022 | -14.26M |
| June 30, 2022 | -14.06M |
| March 31, 2022 | -13.42M |
| December 31, 2021 | -11.22M |
| September 30, 2021 | -9.881M |
| June 30, 2021 | -8.616M |
| March 31, 2021 | -9.033M |
| December 31, 2020 | -8.755M |
| September 30, 2020 | -8.51M |
| June 30, 2020 | -11.81M |
| March 31, 2020 | -12.37M |
| December 31, 2019 | -15.83M |
| September 30, 2019 | -19.57M |
| June 30, 2019 | -19.23M |
| March 31, 2019 | -20.70M |
| December 31, 2018 | -22.30M |
| September 30, 2018 | -22.81M |
| Date | Value |
|---|---|
| June 30, 2018 | -27.41M |
| March 31, 2018 | -31.07M |
| December 31, 2017 | -31.68M |
| September 30, 2017 | -30.74M |
| June 30, 2017 | -28.48M |
| March 31, 2017 | -26.41M |
| December 31, 2016 | -26.09M |
| September 30, 2016 | -27.00M |
| June 30, 2016 | -25.46M |
| March 31, 2016 | -22.73M |
| December 31, 2015 | -19.76M |
| September 30, 2015 | -17.33M |
| June 30, 2015 | -16.13M |
| March 31, 2015 | -14.79M |
| December 31, 2014 | -16.49M |
| September 30, 2014 | -12.30M |
| June 30, 2014 | -8.712M |
| March 31, 2014 | -5.594M |
| December 31, 2013 | -0.031M |
| September 30, 2013 | -0.0308M |
| June 30, 2013 | -0.0306M |
| March 31, 2013 | -0.012M |
Free Cash Flow Range, Past 5 Years
-19.57M
Minimum
Sep 2019
-8.51M
Maximum
Sep 2020
-12.97M
Average
-13.42M
Median
Mar 2022
Free Cash Flow Benchmarks
| Vicarious Surgical Inc | -59.57M |
| Perspective Therapeutics Inc | -37.98M |
| Xtant Medical Holdings Inc | -10.97M |
| Asensus Surgical Inc | -64.19M |
| Catheter Precision Inc | -20.70M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.584M |
| Cash from Investing (Quarterly) | -0.043M |
| Free Cash Flow Per Share (Quarterly) | -0.1126 |
| Free Cash Flow to Equity (Quarterly) | -1.393M |
| Free Cash Flow Yield | -68.27% |